공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 항구토제 시장(2020-2027년)

Global Antiemetic Drugs Market - 2021-2028

리서치사 DataM Intelligence
발행일 On Demand Report 상품 코드 972287
페이지 정보 영문 180 Pages
가격
US $ 4,350 ₩ 5,209,000 PDF & Excel (Single User License)
US $ 4,850 ₩ 5,807,000 PDF & Excel (Multiple User License)
US $ 7,850 ₩ 9,400,000 PDF & Excel (Enterprise License)


세계의 항구토제 시장(2020-2027년) Global Antiemetic Drugs Market - 2021-2028
발행일 : On Demand Report 페이지 정보 : 영문 180 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 항구토제 시장의 성장은 세계 고령 인구의 급속한 확대에 의해 촉진되고 있으며, 대부분이 암 등 질환의 화학요법에서 구토 등의 부작용에 기인하고 있습니다. 또한 위장염 환자 수의 증가도 수요를 촉진하고 있습니다. 그러나 다양한 연구개발 프로세스에서의 비용 상승은 이 시장의 성장을 방해할 가능성이 있습니다.

세계의 항구토제 시장에 대해 조사했으며, 시장 기회, 성장 및 억제요인, 가격 및 규제 분석, COVID-19 팬데믹의 영향, 유형·용도·최종사용자·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 방법과 범위

  • 조사 방법
  • 조사 목적과 조사 범위

제2장 시장 정의와 개요

제3장 개요

  • 유형별
  • 용도별
  • 최종사용자별
  • 지역별

제4장 시장 역학

  • 시장에 영향을 미치는 요인
    • 성장요인
    • 억제요인
    • 시장 기회
    • 영향 분석

제5장 업계 분석

  • Porter의 산업 분석
  • 공급망 분석
  • 가격 분석
  • 규제 분석
  • 상환 분석
  • 미충족 요구

제6장 COVID-19 영향 분석

  • 시장에서 Covid-19의 분석
  • Covid-19 중 가격 역학
  • 수요와 공급 스펙트럼
  • 팬데믹시 시장에 관련된 정부 구상
  • 제조업체의 전략적 구상
  • 결론

제7장 시장 분석 : 약제 유형별

  • 서론
  • 시장 규모 분석 및 전년대비 성장 분석
  • 시장 매력 지수
    • 5-HT3 수용체 길항제
    • 도파민 길항제
    • 스테로이드-코르티코스테로이드
    • 벤조디아제핀
    • NK1 수용체 길항제
    • 항히스타민제
    • 카나비노이드
    • 항콜린제

제8장 시장 분석 : 용도별

  • 서론
  • 시장 규모 분석 및 전년대비 성장 분석
  • 시장 매력 지수
    • 화학요법
    • 임신
    • 멀미
    • 식중독
    • 위장염
    • 현기증
    • 전신 마취제
    • 오피오이드 진통제
    • 정신적 스트레스

제9장 시장 분석 : 최종사용자별

  • 서론
  • 시장 규모 분석 및 전년대비 성장 분석
  • 시장 매력 지수
    • 병원
    • 진료소
    • 요양시설
    • 기타

제10장 시장 분석 : 지역별

  • 서론
  • 시장 규모 분석 및 전년대비 성장 분석
  • 시장 매력 지수
  • 북미
  • 유럽
  • 남미
  • 아시아태평양
  • 중동과 아프리카

제11장 경쟁 구도

  • 경쟁 시나리오
  • 시장 포지셔닝/점유율 분석
  • 합병과 인수 분석

제12장 기업 개요

  • Sanofi
    • 기업 개요
    • 제품 포트폴리오·개요
    • 요점
    • 재무 개요
  • GlaxoSmithKline Pharmaceuticals Limited
  • Johnson & Johnson
  • Merck & Co.
  • Novartis AG
  • Bristol-Myers Squibb
  • Astellas Pharma, Inc.
  • Eli Lilly and Company
  • Abbott
  • Cipla Ltd

제13장 프리미엄 인사이트

제14장 DataM

  • 부록
  • DataM Intelligence·서비스 소개
  • 문의
KSA 20.12.03

Market Overview

The global antiemetic drugs market size was valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Antiemetic drugs are those that have the ability to treat conditions such as nausea and vomiting. They can be used to treat the aforementioned conditions caused by a range of illnesses. Chemotherapy for cancer patients, food poisoning, gastroenteritis, motion sickness and so on can be treated by antiemetic drugs. In case of pregnant women, these drugs bring significant relief to women who have to endure bouts of morning sickness, either during the early phase of the pregnancy.

Market Dynamics

The global antiemetic drugs market growth is driven by the fast expanding of geriatric population worldwide that is highly susceptible to diseases such as cancer which is mostly treated through chemotherapy, something that results in side effects such as vomiting. In addition, growing number of gastroenteritis patients are also serving to stoke demand.

Large companies manufacturing drugs are colleborating with smaller company

Large companies manufacturing drugs, however, are partnering with smaller biotechnology and research companies to come up with newer and more effective antiemetic drugs. The small biotech research companies lack the necessary means to conduct various late stage clinical trials that are usually capital intensive, but often have strong research and development capabilities. Hence, large firms obtain the rights of the drug by paying the small companies one-time. They also pay royalties on recurrent sales. Productivity in the antiemetic drugs market has also declined significantly in the past few years. This has induced companies to rethink before undertaking any new molecule or drug research projects. Hence, large drug manufacturing companies have started collaborating with various small biotechnology and research companies. These small biotech research companies do not have sufficient capital to carry out various late stage clinical trials that incur high capital expenditures, but have strong R&D capabilities. Therefore, large firms obtain the rights of the drug through one-time payment to these small companies and some royalties are paid on recurrent sales. This factors are driving the growth of the market in the forecast period.

Increasing number of people being affected with different types of cancer

Increasing number of people being affected with different types of cancer is another factor driving the growth of the antiemetic drug market. Chemotherapy is one of the standard treatments used to deal with cancer and is also accompanied by side effects of nausea and vomitting. In fact, chemotherapy actually accounts for the largest share of all the applications of the global antiemetic drugs market. This factors are driving the growth of the market in the forecast period.

Rising cost in various research and development processes is likely to hinder the market growth

However, the clinical pipeline for antiemetic drugs is dry and has been identified as one of the major factors likely to restrain the global antiemetic drugs market. Presently, rising cost in various research and development processes is exerting a lot of pressure on various drug making companies. These factors are hampering the growth of the market in the forecast period.

COVID-19 Impact Analysis

People with cancer face an elevated risk of infection and severe sequelae from COVID-19. Dexamethasone is commonly used for antiemetic prophylaxis with systemic therapy for cancer. However, dexamethasone is associated with increased risk of viral and respiratory infections, and causes lymphopenia, which is associated with worse outcomes during COVID-19 infections. Our purpose was to minimize dexamethasone exposure during antiemetic prophylaxis for systemic therapy for solid tumors during the COVID-19 pandemic, while maintaining control of nausea and emesis.

Clinicians should prescribe the minimally effective dose of dexamethasone for antiemetic prophylaxis. Single-day dexamethasone dosing is recommended over multi-day dosing for regimens with high emetogenic risk excluding high-dose cisplatin, preferably in combination with palonosetron, netupitant, and olanzapine. For regimens with low emetogenic risk, 5-HT3 antagonists are recommended over dexamethasone. Thus the pendamic will drive the growth of the market in the forecast period

Segment Analysis

Dopamine antagonists segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

A dopamine antagonist is a chemical, medication or drug that prevents the actions stimulated by dopamine. Dopamine is a naturally produced chemical in the body that binds to regions in the brain to help regulate emotions and movement. Dopamine antagonists disrupt the activity of dopamine by blocking dopamine binding sites without activating them. These medications are used to treat a variety of disorders.

Most dopamine antagonists are used as medications for psychiatric disorders such as schizophrenia, psychosis and sometimes depression. Haloperidol (Haldol), chlorpromazine and risperidone (Risperdal) are classic dopamine antagonists used to treat the symptoms of psychosis -- a mental state in which a person loses touch with reality. Olanzapine (Zyprexa) is a newer dopamine antagonist commonly prescribed for schizophrenia. Dopamine antagonists can also be used for less common health problems, such as Tourette syndrome. Metoclopramide (Reglan) is a dopamine antagonist that is approved for use to treat some cases of severe acid reflux, or gastroesophageal reflux disease, and slow stomach emptying caused by diabetic nerve damage

Antiemetic drug in the dopamine antagonist category include droperidol, metoclopramide, and domperidone. These medications are commonly used to treat nausea or vomiting. Side effects can include restlessness, muscle spasms, and drowsiness.

5-HT3 receptor antagonists has the postive market growth in the forecast period. 5-HT3 receptor antagonists (also called serotonin receptor antagonists or serotonin blockers) are a class of medicines that are used for the prevention and treatment of nausea and vomiting, particularly that caused by chemotherapy, radiation therapy, or postoperatively. 5-HT3 is an abbreviation for serotonin that may also be written as 5-hydroxytryptamine. The first generation 5-HT3 receptor antagonists include dolasetron, granisetron, and ondansetron. Despite variations in their chemical structures and absorption rates, they all work in the same way and are well tolerated. The oral formulations are just as effective at preventing nausea and vomiting as the intravenous forms. These factor are driving the growth of the market in the forecast period.

The chemotherapy are expected to dominate the antiemetic drugs market during the forecast period

Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cells in the body. Chemotherapy is most often used to treat cancer, since cancer cells grow and multiply much more quickly than most cells in the body. Many different chemotherapy drugs are available. Chemotherapy drugs can be used alone or in combination to treat a wide variety of cancers. Though chemotherapy is an effective way to treat many types of cancer, chemotherapy treatment also carries a risk of side effects. Some chemotherapy side effects are mild and treatable, while others can cause serious complications.

Chemotherapy often causes nausea and vomiting. A doctor may prescribe an antiemetic before and after chemo to help prevent these side effects and improve the quality of life. Different types of drugs can help, including serotonin and dopamine receptor blockers, NK1 receptor blockers, and corticosteroids. These factors are driving the market growth in the forecast period.

Geographical Analysis

North America region holds the largest market share global antiemetic drugs market

North America region is dominating the global antiemetic drugs market accounted for the largest market share in 2020, owing to well-established health care infrastructure, technological advancements, and favorable government support in the region. Rapid rise in geriatric population and growing number of cancer patients are boosting market growth in the region. In addition, the highest rate owing to rapid rise of health care infrastructure, rising disposable income of people, improving economic conditions, and increasing purchasing power of people will also drive the growth of the market.

Competitive Landscape

The antiemetic drugs market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson, Sanofi, Merck & Co., Novartis AG, Bristol-Myers Squibb, Astellas Pharma, Inc., Eli Lilly and Company, Abbott, Cipla Ltd., Dr. Reddy's Laboratories Ltd, Baxter International, and IPCA Labs among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the antiemetic drugs market globally.

Sanofi S.A

Overview: Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other.

Product Portfolio: The Company's portfolio comprised of drugs, generic medicines, food supplement, cosmetics, and medical devices such as cancer, cardiology, gynecology, and diabetes.

Why Purchase the Report?

  • Visualize the composition of the antiemetic drugs market segmentation by drug type, application, end-user, and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in antiemetic drugs market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of Antiemetic Drugs market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global antiemetic drugs market report would provide an access to an approximately 45+market data table, 40+ figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Antiemetic Drugs Market - By Drug Type

  • 5-HT3 receptor antagonists
  • Dopamine antagonists
  • Steroid-Corticosteroids
  • Benzodiazepines
  • NK1 receptor antagonist
  • Antihistamines
  • Cannabinoids
  • Anticholinergic

Global Antiemetic Drugs Market - By Application

  • Chemotherapy
  • Pregnancy
  • Motion Sickness
  • Food Poisoning
  • Gastroenteritis
  • Diziness
  • General Anesthetics
  • Opiod Analgesic
  • Emotional Stress

Global Antiemetic Drugs Market -By End-User

  • Hospital
  • Clinic
  • Nursing Home
  • Other

Global Antiemetic Drugs Market - By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

1. Global Antiemetic Drugs Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Antiemetic Drugs Market - Market Definition and Overview

3. Global Antiemetic Drugs Market - Executive Summary

  • 3.1. Market Snippet by Drug Type
  • 3.2. Market snippet by Application
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Global Antiemetic Drugs Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing number of gastroenteritis patients
      • 4.1.1.2. Increasing number of people being affected with different types of cancer
    • 4.1.2. Restraints:
      • 4.1.2.1. Rising cost in various research and development processes
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Antiemetic Drugs Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Antiemetic Drugs Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Antiemetic Drugs Market - By Drug Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type Segment
    • 7.1.2. Market Attractiveness Index, By Drug Type Segment
  • 7.2. 5-HT3 receptor antagonists *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Dopamine antagonists
  • 7.4. Steroid-Corticosteroids
  • 7.5. Benzodiazepines
  • 7.6. NK1 receptor antagonist
  • 7.7. Antihistamines
  • 7.8. Cannabinoids
  • 7.9. Anticholinergic

8. Global Antiemetic Drugs Market - By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Chemotherapy *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Pregnancy
  • 8.4. Motion Sickness
  • 8.5. Food Poisoning
  • 8.6. Gastroenteritis
  • 8.7. Diziness
  • 8.8. General Anesthetics
  • 8.9. Opiod Analgesics
  • 8.10. Emotional Stress

9. Global Antiemetic Drugs Market - By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
    • 9.1.2. Market Attractiveness Index, By End-User Segment
  • 9.2. Hospital *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Clinic
  • 9.4. Nursing Home
  • 9.5. Other

10. Global Antiemetic Drugs Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6.
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6.
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Global Antiemetic Drugs Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of key companies to watch
  • 11.5. List of the company with disruptive technology
  • 11.6. List of start-up companies

12. Global Antiemetic Drugs Market- Company Profiles

  • 12.1. Sanofi*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. GlaxoSmithKline Pharmaceuticals Limited
  • 12.3. Johnson & Johnson
  • 12.4. Merck & Co.
  • 12.5. Novartis AG
  • 12.6. Bristol-Myers Squibb
  • 12.7. Astellas Pharma, Inc.
  • 12.8. Eli Lilly and Company
  • 12.9. Abbott
  • 12.10. Dr. Reddy's Laboratories

LIST NOT EXHAUSTIVE

13. Global Antiemetic Drugs Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us
Back to Top
전화 문의
F A Q